NaCl 0.9% in Glucose 5% + 40mmol/L Potassium — Competitive Intelligence Brief

NaCl 0.9% in Glucose 5% + 40mmol/L Potassium (NaCl 0.9% in Glucose 5% + 40mmol/L Potassium) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid replacement / Electrolyte solution. Area: Critical Care / Fluid and Electrolyte Management.

marketed Intravenous fluid replacement / Electrolyte solution Critical Care / Fluid and Electrolyte Management Small molecule

Target snapshot

NaCl 0.9% in Glucose 5% + 40mmol/L Potassium (NaCl 0.9% in Glucose 5% + 40mmol/L Potassium) — Niels Van Regenmortel. This intravenous fluid replacement solution provides sodium chloride, glucose, and potassium to restore electrolyte balance and provide hydration and calories.

Comparator set

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
NaCl 0.9% in Glucose 5% + 40mmol/L Potassium TARGET	NaCl 0.9% in Glucose 5% + 40mmol/L Potassium	Niels Van Regenmortel	marketed	Intravenous fluid replacement / Electrolyte solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid replacement / Electrolyte solution class)

1. Niels Van Regenmortel · 1 drug in this class